Description
Semaglutide research peptide
Semaglutide is a long-acting synthetic analogue of glucagon-like peptide-1 (GLP-1). It was modified with an amino-acid substitution and a fatty-acid side chain so that it stays in circulation far longer than native GLP-1. It is one of the most extensively characterised GLP-1 receptor agonists in metabolic research. Pure Rawz supplies semaglutide as a lyophilised research peptide.
Product details
| Compound | Semaglutide |
|---|---|
| Class | GLP-1 receptor agonist (peptide analogue) |
| Format | Lyophilised peptide vial |
| Labelling | Compound name and strength on every vial |
What research has examined
- GLP-1 receptor signalling: glucose-dependent insulin secretion, glucagon regulation and gastric emptying.
- Appetite and energy-balance pathways: how GLP-1 receptor activation in the brain influences satiety signalling.
- Large clinical trial programmes: semaglutide has been studied extensively in randomised trials, including the STEP programme published in the New England Journal of Medicine.
Regulatory status
Approved semaglutide medicines are prescription-only, licensed products made by their manufacturer. The material sold here is a research chemical. It is not one of those medicines, it is not approved for any use in humans, and it must not be used as a substitute for them.
Storage and handling
Store lyophilised vials refrigerated or frozen, protected from light. Reconstitute using a suitable sterile diluent under aseptic conditions and refrigerate the solution. See our peptide reconstitution guide.
Related research products
Retatrutide · Cagrilintide · Survodutide · All research peptides
References
For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.
Reviews
There are no reviews yet.